Showing latest transactions and SEC Form 4 filings for ALNY.
6 results.
| X | Filing Date | Trade Date | Ticker | Company Name | Insider Name | Title | Trade Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-17 16:06:16 | 2026-11-13 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer, Director | G | $0.00 | +11,000 | 85,209 | 0% | $0 | |
| D | 2026-11-12 16:07:18 | 2026-11-10 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | PYOTT DAVID E I | Director | M - OptEx | $36.00 | +7,560 | 33,262 | 0% | +$272,122 |
| 2026-11-12 16:05:24 | 2026-11-10 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sigal Charles Elliott | Director | P - Purchase | $152.25 | +1,600 | 5,046 | +46% | +$243,600 | |
| 2026-11-12 16:01:56 | 2026-11-09 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | SCHULMAN AMY W | Director | P - Purchase | $156.82 | +1,910 | 25,959 | +8% | +$299,526 | |
| 2026-10-06 16:12:25 | 2026-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | SUPRAN BRYAN | EVP, CLO and Secretary | S - Sale | $226.88 | -1,758 | 12,807 | -12% | -$398,855 |